Evidence map›Paper›PMID 33946667›Full record

ArticleInternational journal of molecular sciences2021

Therapeutic Effects of hiPSC-Derived Glial and Neuronal Progenitor Cells-Conditioned Medium in Experimental Ischemic Stroke in Rats.

Diana Salikhova, Tatiana Bukharova, Elvira Cherkashova, Daria Namestnikova, Georgy Leonov, Maria Nikitina, Ilya Gubskiy, Gevorg Akopyan, Andrey Elchaninov, Konstantin Midiber and 8 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 1 country.

Diana SalikhovaResearch Centre for Medical Genetics, 115522 Moscow, Russia.ORCID 0000-0001-7842-7635
Tatiana BukharovaResearch Centre for Medical Genetics, 115522 Moscow, Russia.ORCID 0000-0003-0481-256X
Elvira CherkashovaDepartment of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University, 117997 Moscow, Russia.ORCID 0000-0001-9549-9104
Daria NamestnikovaDepartment of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University, 117997 Moscow, Russia.ORCID 0000-0001-6635-511X
Georgy LeonovResearch Centre for Medical Genetics, 115522 Moscow, Russia.ORCID 0000-0002-5632-7040
Maria NikitinaResearch Institute of Human Morphology, 117418 Moscow, Russia.
Ilya GubskiyDepartment of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University, 117997 Moscow, Russia.ORCID 0000-0003-1726-6801
Gevorg AkopyanRadiology and Clinical Physiology Scientific Research Center, Federal State Budgetary Institution "Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency", 117997 Moscow, Russia.ORCID 0000-0003-2889-3405
Andrey ElchaninovResearch Institute of Human Morphology, 117418 Moscow, Russia.ORCID 0000-0002-2392-4439
Konstantin MidiberResearch Institute of Human Morphology, 117418 Moscow, Russia.
Natalia BulatencoResearch Centre for Medical Genetics, 115522 Moscow, Russia.
Victoria MokrousovaResearch Centre for Medical Genetics, 115522 Moscow, Russia.
Andrey MakarovDepartment of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University, 117997 Moscow, Russia.ORCID 0000-0003-2133-2293
Konstantin YaryginInstitute of Biomedical Chemistry, 119121 Moscow, Russia.ORCID 0000-0002-2261-851X
Vladimir ChekhoninDepartment of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University, 117997 Moscow, Russia.
Liudmila MikhalevaResearch Institute of Human Morphology, 117418 Moscow, Russia.
Timur FatkhudinovResearch Institute of Human Morphology, 117418 Moscow, Russia.ORCID 0000-0002-6498-5764
Dmitry GoldshteinResearch Centre for Medical Genetics, 115522 Moscow, Russia.
Pirogov Russian National Research Medical University · RUResearch Centre for Medical Genetics · RUResearch Institute of Human Morphology · RUPeoples' Friendship University of Russia · RUFederal Medical-Biological Agency · RURussian Medical Academy of Continuous Professional Education · RU

Funding

Ministry of Science and Higher Education of the Russian Federation
6 · The paper itself

Abstract

Transplantation of various types of stem cells as a possible therapy for stroke has been tested for years, and the results are promising. Recent investigations have shown that the administration of the conditioned media obtained after stem cell cultivation can also be effective in the therapy of the central nervous system pathology (hypothesis of their paracrine action). The aim of this study was to evaluate the therapeutic effects of the conditioned medium of hiPSC-derived glial and neuronal progenitor cells in the rat middle cerebral artery occlusion model of the ischemic stroke. Secretory activity of the cultured neuronal and glial progenitor cells was evaluated by proteomic and immunosorbent-based approaches. Therapeutic effects were assessed by overall survival, neurologic deficit and infarct volume dynamics, as well as by the end-point values of the apoptosis- and inflammation-related gene expression levels, the extent of microglia/macrophage infiltration and the numbers of formed blood vessels in the affected area of the brain. As a result, 31% of the protein species discovered in glial progenitor cells-conditioned medium and 45% in neuronal progenitor cells-conditioned medium were cell type specific. The glial progenitor cell-conditioned media showed a higher content of neurotrophins (BDNF, GDNF, CNTF and NGF). We showed that intra-arterial administration of glial progenitor cells-conditioned medium promoted a faster decrease in neurological deficit compared to the control group, reduced microglia/macrophage infiltration, reduced expression of pro-apoptotic gene

Indexed as

AnimalsCells, CulturedCulture Media, ConditionedDisease Models, AnimalHumansInduced Pluripotent Stem CellsInfarction, Middle Cerebral ArteryInfusions, Intra-ArterialIschemic StrokeMaleNeural Stem CellsNeurogliaRatsRats, WistarCulture Media, Conditionedconditioned mediumglial progenitor cellsinduced pluripotent stem cells (iPSCs)ischemic strokeMCAOneuronal progenitor cells

Identifiers

PMID33946667
PMCPMC8125106
OpenAlexW3159391833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.